Cargando…
New developments and opportunities in drugs being trialed for amyotrophic lateral sclerosis from 2020 to 2022
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder that primarily affects motor neurons in the brain and spinal cord. In the recent past, there have been just two drugs approved for treatment, riluzole and edaravone, which only prolong survival by a few months. However,...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742490/ https://www.ncbi.nlm.nih.gov/pubmed/36518658 http://dx.doi.org/10.3389/fphar.2022.1054006 |